Stock PMN PROMIS NEUROSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus ProMIS Neurosciences, Inc.

Equities

PMN

CA74346M4065

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
1.83 USD -0.81% Intraday chart for ProMIS Neurosciences, Inc. -5.68% +59.12%
May. 15 ProMIS Neurosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 30 ProMIS Neurosciences, Inc. Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies CI

Evolution of the average Target Price on ProMIS Neurosciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

d56f5729e328963eba8b1.dGu7s0IKKsKd9RZt2-chtzyJjvkUUBn_zLzmphaaJ_o.Izj5xRhafYryjWAKndAR5Hvo39RBNV27vIvSxHrPbZ9HEdnjCGITm-6AUw~677c4da73ae605725a8c64dd0fb90bb4

Analyst Recommendations on ProMIS Neurosciences, Inc.

BTIG Starts ProMIS Neurosciences With Buy Rating, Price Target is $8 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.497 CAD
Average target price
12.02 CAD
Spread / Average Target
+381.37%
High Price Target
13.05 CAD
Spread / Highest target
+422.69%
Low Price Target
10.99 CAD
Spread / Lowest Target
+340.04%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ProMIS Neurosciences, Inc.

BTIG

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PMN Stock
  4. Consensus ProMIS Neurosciences, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW